The DOI matches its Crossref record; 136 of the 140 references it cites were found in a registry or an index.
Size and burden of mental disorders in Europe—a critical review and appraisal of 27 studies
Open accessAbstract
Epidemiological data on a wide range of mental disorders from community studies conducted in European countries are presented to determine the availability and consistency of prevalence, disability and treatment findings for the EU. Using a stepwise multimethod approach, 27 eligible studies with quite variable designs and methods including over 150,000 subjects from 16 European countries were identified. Prevalence: On the basis of meta-analytic techniques as well as on reanalyses of selected data sets, it is estimated that about 27% (equals 82.7 million; 95% CI: 78.5-87.1) of the adult EU population, 18-65 of age, is or has been affected by at least one mental disorder in the past 12 months. Taking into account the considerable degree of comorbidity (about one third had more than one disorder), the most frequent disorders are anxiety disorders, depressive, somatoform and substance dependence disorders. When taking into account design, sampling and other methodological differences between studies, little evidence seems to exist for considerable cultural or country variation. Disability and treatment: despite very divergent and fairly crude assessment strategies, the available data consistently demonstrate (a) an association of all mental disorders with a considerable disability burden in terms of number of work days lost (WLD) and (b) generally low utilization and treatment rates. Only 26% of all cases had any consultation with professional health care services, a finding suggesting a considerable degree of unmet need. The paper highlights considerable future research needs for coordinated EU studies across all disorders and age groups. As prevalence estimates could not simply be equated with defined treatment needs, such studies should determine the degree of met and unmet needs for services by taking into account severity, disability and comorbidity. These needs are most pronounced for the new EU member states as well as more generally for adolescent and older populations.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“in line with the higher prevalence of women who make use of mental healthcare services”
From Patients requesting and receiving euthanasia for psychiatric disorders in the Netherlands (2023) · cites this paper as [12]
In the citing paper
“In Europe, only about 25% of people with mental disorders receive professional treatment (Wittchen and Jacobi, 2005).”
From Feasibility of a Software agent providing a brief Intervention for Self-help to Uplift psychological wellbeing (“SISU”). A single-group pretest-posttest trial investigating the potential of SISU to act as therapeutic agent (2021) · cites this paper as Wittchen and Jacobi, 2005
In the citing paper
“It is the case that many with anxiety disorders have no diagnosis nor seek treatment [29,30].”
From Low-intensity internet-delivered treatment for generalized anxiety symptoms in routine care: protocol for a randomized controlled trial (2014) · cites this paper as [30]
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
American Psychiatric Association (2013) · doi:10.1176/appi.books.9780890425596 · Cited by 116,369
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. B. (2013) · Oxford University Press eBooks · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,845
An inventory for measuring depression
BECK, A. T. (1961) · Archives of General Psychiatry · doi:10.1001/archpsyc.1961.01710120031004 · Cited by 38,032
(1998) · The Journal of Clinical Psychiatry · Cited by 19,139
WARE, J. E., KOSINSKI, M., & KELLER, S. D. (1996) · Medical Care · doi:10.1097/00005650-199603000-00003 · Cited by 17,392 · cited 1×
“The only available cross-national and directly comparative data in this respect come from the ESEMeD study revealing that health-related quality of life (mental health score of the SF12, Ware et al., 1996) was reduced by approximately 1.0 standard deviation units in most mental disorders.”
ResultInfluentialDiagnostic and Statistical Manual of Mental Disorders
&NA; (1988) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-198802020-00022 · Cited by 12,603
Kessler, R. C. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950010008002 · Cited by 12,370 · cited 3×
“Consistent with the international situation and other inquiries (e.g. Kessler et al., 1994; Fryers et al., 2004), almost no community studies with established explicit diagnostic criteria were identified with regard to other mental disorders such as sleep disorders, impulse control disorders,…”
BackgroundResultDiagnostic and Statistical Manual of Mental Disorders, 3rd ed
Cooper, A. M., & Michels, R. (1981) · American Journal of Psychiatry · doi:10.1176/ajp.138.1.128 · Cited by 7,419
The mini international neuropsychiatric interview
Lecrubier, Y., Sheehan, D. V., Hergueta, T., & Weiller, E. (1998) · European Psychiatry · doi:10.1016/s0924-9338(99)80239-9 · Cited by 5,899
A scaled version of the General Health Questionnaire
Goldberg, D. P., & Hillier, V. F. (1979) · Psychological Medicine · doi:10.1017/s0033291700021644 · Cited by 5,639 · cited 1×
“We did not include studies assessing psychopathology and mental health exclusively by means of questionnaires or screening instruments (e.g. GHQ, Goldberg and Hillier, 1979; CIDI-SF, Kessler et al., 1998; MHI-5, Berwick et al., 1991).”
Method
Research works printed but not linked: 6
- Andrade, 2000, Cross-national comparisons of the prevalences and correlates of mental disorders, B. World Health Organ., 78, 413
- Jacobi, 2004, Psychische Störungen in der Allgemeinbevölkerung: Inanspruchnahme von Gesundheitsleistungen und Ausfalltage, Bundesgesundheitsblatt Gesundh. Forsch. Gesundh.Schutz, 47, 736
- Meyer, 2001, Prevalence of DSM-IV psychiatric disorders including nicotine dependence in the general population: results from the northern german TACOS study, Neurol. Psychiatr. Br., 9, 75
- Szadoczky, 2000, A hangulat- es szorongasos zavarok elöfordulasa a felnott magyar lakossag köreben, Orv. Hetil., 141, 17
- The WHO World Mental Health Survey Consortium, 2004, Prevalence, severity, and unmet need for treatment of mental disorders in the World Health Organization World Mental Health Surveys, J. Am. Med. Assoc., 291, 2581, 10.1001/jama.291.21.2581 · DOI · Paper page
- Wittchen, 2003, Depression—an underdiagnosed disease, Medicographia, 25, 9
Cited by
Sorted by citations
Items 101–200 of 1,000
Lintvedt, O. K., Griffiths, K. M., Sørensen, K., Østvik, A. R., Wang, C. E. A., Eisemann, M., & Waterloo, K. (2013) · Clinical Psychology & Psychotherapy · doi:10.1002/cpp.770 · Cited by 157
Evidence-based pharmacological treatment of generalized anxiety disorder
Baldwin, D. S., Waldman, S., & Allgulander, C. (2011) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145710001434 · Cited by 183
“A review of epidemiological studies in Europe suggests a 12-month prevalence of 1.2–1.9%, and a lifetime prevalence of 4.3–5.9% (Wittchen & Jacobi, 2005).”
BackgroundInfluentialAlcohol use disorders in EU countries and Norway: An overview of the epidemiology
Rehm, J. T., Room, R., van den Brink, W., & Jacobi, F. (2005) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2005.04.005 · Cited by 169
Self-citationCost of anxiety disorders in Europe
Andlin‐Sobocki, P., & Wittchen, H. ‐. (2005) · European Journal of Neurology · doi:10.1111/j.1468-1331.2005.01196.x · Cited by 165
Bowler, J. O., Mackintosh, B., Dunn, B. D., Mathews, A., Dalgleish, T., & Hoppitt, L. (2012) · Journal of Consulting and Clinical Psychology · doi:10.1037/a0029932 · Cited by 164
“In Europe, only one quarter of those affected by mental illness are in any form of treatment, indicating considerable unmet need (Wittchen & Jacobi, 2005).”
BackgroundValenza, G., Nardelli, M., Lanatà, A., Gentili, C., Bertschy, G., Paradiso, R., & Scilingo, E. P. (2013) · IEEE Journal of Biomedical and Health Informatics · doi:10.1109/jbhi.2013.2290382 · Cited by 166
Lanatà, A., Valenza, G., Nardelli, M., Gentili, C., & Scilingo, E. P. (2014) · IEEE Journal of Biomedical and Health Informatics · doi:10.1109/jbhi.2014.2360711 · Cited by 168
Disorders Without Borders? The Expanding Scope of Psychiatric Practice
Rose, N. (2006) · BioSocieties · doi:10.1017/s1745855206004078 · Cited by 177
Madianos, M. G., Economou, M. P., Alexiou, T., & Stefanis, C. N. (2010) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-010-0265-4 · Cited by 162
“These adverse phenomena were significantly associated with health and mental health problems, and particularly with depression [24–37].”
BackgroundAnxiety symptoms among Chinese nurses and the associated factors: a cross sectional study
Gao, Y., Pan, B., Sun, W., Wu, H. L., Wang, J., & Wang, L. (2012) · BMC Psychiatry · doi:10.1186/1471-244x-12-141 · Cited by 175
“In a more recent systematic review of studies conducted in 16 European countries, however, this value was estimated to be 12% [6].”
BackgroundPrevalence of common mental disorders in Italy
de Girolamo, G., Polidori, G., Morosini, P., Scarpino, V., Reda, V., Serra, G., Mazzi, F., Alonso, J., Vilagut, G., Visonà, G., et al. (2006) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-006-0097-4 · Cited by 159
Biological markers of generalized anxiety disorder
Maron, E., & Nutt, D. (2017) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2017.19.2/dnutt · Cited by 164
Bandelow, B., Allgulander, C., Baldwin, D. S., Costa, D. L. D. C., Denys, D., Dilbaz, N., Domschke, K., Eriksson, E., Fineberg, N. A., Hättenschwiler, J., et al. (2023) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2022.2086295 · Cited by 158
“For OCD, it was 1.5 (Wittchen and Jacobi 2005) and for PTSD 3.22 (Alonso et al. 2004a).”
BackgroundInfluentialPrevalence of Anxiety in University Students during the COVID-19 Pandemic: A Systematic Review
Liyanage, S., Saqib, K., Khan, A. F., Thobani, T. R., Tang, W., Chiarot, C. B., AlShurman, B. A., & Butt, Z. A. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19010062 · Cited by 186
“Anxiety disorders are the most prevalent mental health disorders and affect approximately one-third of adults during their lifetime [74,75].”
BackgroundHøifødt, R. S., Lillevoll, K. R., Griffiths, K. M., Wilsgaard, T., Eisemann, M., Waterloo, K., & Kolstrup, N. (2013) · Journal of Medical Internet Research · doi:10.2196/jmir.2714 · Cited by 154
“Most patients with psychological problems will receive most or all of their mental health care in primary care, and findings suggest that many patients prefer to consult their GP for treatment of depression [2,38-40].”
BackgroundECNP consensus meeting. Bipolar depression. Nice, March 2007
Goodwin, G. M., Anderson, I. M., Arango, C., Bowden, C. L., Henry, C., Mitchell, P. B., Nolen, W. A., Vieta, E., & Wïttchen, H. (2008) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2008.03.003 · Cited by 153
Canuto, A., Weber, K., Baertschi, M., Andreas, S., Volkert, J., Dehoust, M. C., Sehner, S., Suling, A. I., Wegscheider, K., Ausín, B., et al. (2017) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2017.08.015 · Cited by 153
Agoraphobia: a review of the diagnostic classificatory position and criteria
Wittchen, H.-U., Gloster, A. T., Beesdo-Baum, K., Fava, G. A., & Craske, M. G. (2010) · Depression and Anxiety · doi:10.1002/da.20646 · Cited by 150
“The variation between studies has been attributed to design, methodological, and assessment variation rather than reflecting true differences; for example, as a function of cultural or regional effects.([47,55]) An important example of such a methodological factor is the different conventions used for the DSM-IV ‘‘A’’…”
BackgroundMethodFineberg, N. A., Reghunandanan, S., Simpson, H. B., Phillips, K. A., Richter, M. A., Matthews, K., Stein, D. J., Sareen, J., Brown, A., & Sookman, D. (2015) · Psychiatry Research · doi:10.1016/j.psychres.2014.12.003 · Cited by 150
“It affects 2–3% of the adult population (and 1% of children) regardless of ethnicity, geography or socioeconomic status (Robins et al., 1984; Weissman et al., 1994; Heyman et al., 2003; Wittchen and Jacobi, 2005).”
BackgroundKersemaekers, W., Rupprecht, S., Wittmann, M., Tamdjidi, C., Falke, P., Donders, R., Speckens, A., & Kohls, N. (2018) · Frontiers in Psychology · doi:10.3389/fpsyg.2018.00195 · Cited by 148
Skapinakis, P., Bellos, S., Koupidis, S. A., Grammatikopoulos, I. A., Theodorakis, P. N., & Mavreas, V. G. (2013) · BMC Psychiatry · doi:10.1186/1471-244x-13-163 · Cited by 160
“Wittchen & Jacobi in 2005 [36] reviewed 27 general adult population studies conducted in Europe and have recently (2011) updated this review extending their coverage to children and adolescent studies [5].”
BackgroundHowells, F. M., Stein, D. J., & Russell, V. A. (2012) · Metabolic Brain Disease · doi:10.1007/s11011-012-9287-9 · Cited by 161
Nordgren, L. B., Hedman, E., Etienne, J., Bodin, J., Kadowaki, Å., Eriksson, S., Lindkvist, E., Andersson, G., & Carlbring, P. (2014) · Behaviour Research and Therapy · doi:10.1016/j.brat.2014.05.007 · Cited by 145
“Despite these high numbers of individuals suffering from anxiety disorders, only a small proportion receive adequate treatment (Weisberg, Dyck, Culpepper, & Keller, 2007; Wittchen & Jacobi, 2005).”
BackgroundEffect of Cognitive-Behavioral Therapy on Neural Correlates of Fear Conditioning in Panic Disorder
Kircher, T. T. J., Arolt, V., Jansen, A., Pyka, M., Reinhardt, I., Kellermann, T., Konrad, C., Lueken, U., Gloster, A. T., Gerlach, A. L., et al. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.07.026 · Cited by 158
Specificity of performance monitoring changes in obsessive-compulsive disorder
Endrass, T., & Ullsperger, M. (2014) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2014.03.024 · Cited by 141
“anging between 1 and 3% (Karno et al., 1988; Ruscio et al., 2010; eissman et al., 1994; Wittchen and Jacobi, 2005) and a high roportion of chronic illness courses.”
BackgroundRyan, S., Jorm, A. F., Toumbourou, J. W., & Lubman, D. I. (2015) · Early Intervention in Psychiatry · doi:10.1111/eip.12211 · Cited by 143
Mental health, poverty and development
Funk, M., Drew, N., & Knapp, M. R. J. (2012) · Journal of Public Mental Health · doi:10.1108/17465721211289356 · Cited by 146
The economic burden of depression in Sweden from 1997 to 2005
Sobocki, P., Lekander, I., Borgström, F., Ström, O., & Runeson, B. (2006) · European Psychiatry · doi:10.1016/j.eurpsy.2006.10.006 · Cited by 149
Charlson, F., Moran, A. E., Freedman, G., Norman, R. E., Stapelberg, N. J. C., Baxter, A. J., Vos, T., & Whiteford, H. (2013) · BMC Medicine · doi:10.1186/1741-7015-11-250 · Cited by 149
“This approach provides a consistent method for estimating the changes in population health as a function of decreasing or increasing the level of exposure to risk factors [29].”
Mitchell, A. J., Pereira, I. E. S., Yadegarfar, M., Pepereke, S., Mugadza, V., & Stubbs, B. (2014) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.114.147629 · Cited by 138
Chronic obstructive pulmonary disease and cerebrovascular disease: A comprehensive review
Lahousse, L., Tiemeier, H. W., Ikram, M. A., & Brusselle, G. (2015) · Respiratory Medicine · doi:10.1016/j.rmed.2015.07.014 · Cited by 140
“By focusing on mortality rates rather than disability rates, the large burden of neurological disorders has been underestimated in Europe [4].”
BackgroundAntidepressant Utilization and Suicide in Europe: An Ecological Multi-National Study
Gusmão, R., Quintão, S., McDaid, D., Arensman, E., Van Audenhove, C., Coffey, C., Värnik, A., Värnik, P., Coyne, J., & Hegerl, U. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066455 · Cited by 136
“Moreover, there is increased awareness of the extent of the impact of poor mental health and the increased need for treatment and support in Europe [76,77], varying from country to country [78], that may also contribute to this increase in antidepressant prescribing.”
BackgroundTotal somatic symptom score as a predictor of health outcome in somatic symptom disorders
Tomenson, B., Essau, C. A., Jacobi, F., Ladwig, K., Leiknes, K. A., Lieb, R., Meinlschmidt, G., McBeth, J., Rosmalen, J. G. M., Rief, W., et al. (2013) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.112.114405 · Cited by 149
Self-citationLewer, D., O'Reilly, C., Mojtabai, R., & Evans-Lacko, S. (2015) · British Journal of Psychiatry · doi:10.1192/bjp.bp.114.156786 · Cited by 150
fMRI neurofeedback facilitates anxiety regulation in females with spider phobia
Zilverstand, A., Sorger, B., Sarkheil, P., & Goebel, R. (2015) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2015.00148 · Cited by 133
“Anxiety disorders are the most common mental health condition, with a year-prevalence of 12–18% (Wittchen and Jacobi, 2005; Kessler et al., 2011, 2012).”
BackgroundInfluentialCarroll, H. A., Hook, K., Perez, O. F. R., Denckla, C. A., Cooper‐Vince, C. E., Ghebrehiwet, S., Ando, K., Touma, M., Borba, C. P. C., Fricchione, G. L., et al. (2020) · Psychiatry Research · doi:10.1016/j.psychres.2020.113236 · Cited by 156
Barth, J., Münder, T., Gerger, H., Nüesch, E., Trelle, S., Znoj, H., Jüni, P., & Cuijpers, P. J. (2016) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.140201 · Cited by 140
“Depressive disorders can lower the ability to function in work and daily life [4].”
The Use of Computerized Self-Help Packages to Treat Adolescent Depression and Anxiety
Sethi, S., Campbell, A. J., & Ellis, L. A. (2010) · Journal of Technology in Human Services · doi:10.1080/15228835.2010.508317 · Cited by 129
“Given that depression and anxiety are major causes of disability on both a national and global scale, the development of effective large scale treatment programmes is a priority (Robertson, Smith, Castle, & Tannenbaum, 2006 ; Wittchen & Jacobi, 2005 ; Christensen, Griffiths, & Jorm, 2004 ).”
BackgroundWhy mental health matters to global health
Patel, V. (2014) · Transcultural Psychiatry · doi:10.1177/1363461514524473 · Cited by 151
Rugulies, R., Sørensen, K., Tecco, C. D., Bonafede, M., Rondinone, B. M., Ahn, S., Ando, E., Ayuso‐Mateos, J. L., Cabello, M., Descatha, A., et al. (2021) · Environment International · doi:10.1016/j.envint.2021.106629 · Cited by 144
The balanced care model for global mental health
Thornicroft, G., & Tansella, M. (2013) · Psychological Medicine · doi:10.1017/s0033291712001420 · Cited by 162
“For the second source of information used in developing this conceptual model, information from experts in many countries worldwide, we first contacted colleagues from across Africa, the Americas, Asia, Australasia and Europe whom we knew to be active in mental health service design in their respective countries.”
BackgroundInfluentialLong-term efficacy of pregabalin in generalized anxiety disorder
Feltner, D. E., Wïttchen, H., Kavoussi, R. J., Brock, J., Baldinetti, F., & Pande, A. C. (2008) · International Clinical Psychopharmacology · doi:10.1097/yic.0b013e3282f0f0d7 · Cited by 130
Burri, A. V., & Maercker, A. R. A. (2014) · BMC Research Notes · doi:10.1186/1756-0500-7-407 · Cited by 129
“As previously mentioned, all analyses were additionally conducted excluding Croatia.”
BackgroundMethodInfluentialEvidence-based pharmacotherapy of Generalized Anxiety Disorder
Baldwin, D. S., & Polkinghorn, C. (2005) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145704004870 · Cited by 132
Deep brain stimulation: indications and evidence
Pereira, E. A. C., Green, A. L., Nandi, D., & Aziz, T. Z. (2007) · Expert Review of Medical Devices · doi:10.1586/17434440.4.5.591 · Cited by 129
Melzig, C. A., Weike, A. I., Hamm, A. O., & Thayer, J. F. (2009) · International Journal of Psychophysiology · doi:10.1016/j.ijpsycho.2008.07.013 · Cited by 126
Magnitude and impact of comorbidity of mental disorders from epidemiologic surveys
Merikangas, K. R., & Kalaydjian, A. (2007) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e3281c61dc5 · Cited by 122
Negt, P., Brakemeier, E., Michalak, J., Winter, L., Bleich, S., & Kahl, K. G. (2016) · Brain and Behavior · doi:10.1002/brb3.486 · Cited by 126
“High rates of relapse and recurrence, considerable functional impairments, and pro-tracted lifetime courses frequently occur (Michalak and Lam 2002; Wittchen and Jacobi 2005; Mondimore et al. 2007).”
Pregabalin for the treatment of generalized anxiety disorder: an update
Baldwin, D. S., Ajel, Nowak, Rafiq, & Masdrakis, V. G. (2013) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s36453 · Cited by 127
“9%.(2) It is probably the most common anxiety disorder among the elderly population.”
Lifetime Traumatic Experiences and Posttraumatic Stress Disorder in the German Population
Hauffa, R., Rief, W., Brähler, E., Martin, A., Mewes, R., & Glaesmer, H. (2011) · The Journal of Nervous and Mental Disease · doi:10.1097/nmd.0b013e3182392c0d · Cited by 130
“Valid epidemiological data are necessary to quantify this effect on the one hand and improve general health care on the other (Wittchen and Jacobi, 2005).”
BackgroundCross-cultural variations in the prevalence and presentation of anxiety disorders
Marques, L., Robinaugh, D. J., LeBlanc, N. J., & Hinton, D. (2011) · Expert Review of Neurotherapeutics · doi:10.1586/ern.10.122 · Cited by 122
Discrimination against people with mental illness: what can psychiatrists do?
Thornicroft, G., Rose, D. S., & Mehta, N. (2010) · Advances in Psychiatric Treatment · doi:10.1192/apt.bp.107.004481 · Cited by 135
Pharmacotherapy of obsessive–compulsive disorder: evidence-based treatment and beyond
Fineberg, N. A., Reghunandanan, S., Brown, A., & Pampaloni, I. (2013) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867412461958 · Cited by 122
“…and Statistical Manual of Mental Disorders third edition, third revised edition and fourth edition (DSM-III, DSM-III-R and DSM-IV) criteria suggest lifetime prevalence to range between 1% and 3% of the worldwide population (Robins et al., 1984; Weissman et al., 1994; Wittchen and Jacobi, 2005).”
BackgroundJuegos serios para el tratamiento o la prevención de la depresión: una revisión sistemática
Fleming, T. M., Cheek, C., Merry, S. N., Thabrew, H., Bridgman, H., Stasiak, K., Shepherd, M., Perry, Y., & Hetrick, S. (2015) · Revista de Psicopatología y Psicología Clínica · doi:10.5944/rppc.vol.19.num.3.2014.13904 · Cited by 120
Fineberg, N. A., Hengartner, M. P., Bergbaum, C., Gale, T. M., Gamma, A., Ajdacic‐Gross, V., Wulf Rössler, A., & Angst, J. (2012) · International Journal of Psychiatry in Clinical Practice · doi:10.3109/13651501.2012.755206 · Cited by 127
“…et al. 2005a, b) and European citizens (Wittchen and Jacobi 2005), using diagnostic instruments compatible with the DSM-IV, produced a somewhat more conservative estimate of a 1.6% (Kessler et al. 2005a, b) and 0.8% (Wittchen and Jacobi 2005; Wittchen et al. 2011) lifetime prevalence, respectively.”
MethodInfluentialMitochondria and the economy of stress (mal)adaptation
Morava, É., & Kozicz, T. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.02.005 · Cited by 121
“, 2007), and like humans, rodents prone to develop a depression-like phenotype represent 15–20% of the total population (Schmidt, 2011; Wittchen and Jacobi, 2005; Wittchen et al., 2005).”
BackgroundMayo-Wilson, E., & Montgomery, P. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005330.pub4 · Cited by 112
Nakash, O., Levav, I., Aguilar-Gaxiola, S., Alonso, J., Andrade, L. H., Angermeyer, M. C., Bruffaerts, R., Caldas-de-Almeida, J. M., Florescu, S., de Girolamo, G., et al. (2014) · Psycho-Oncology · doi:10.1002/pon.3372 · Cited by 117
“It exceeds 50% worldwide, and it approaches 90% in the least resourced countries for common mental disorders [27–31].”
Capacity Building in Global Mental Health Research
Thornicroft, G., Cooper, S., Bortel, T. V. V., Kakuma, R., & Lund, C. (2012) · Harvard Review of Psychiatry · doi:10.3109/10673229.2012.649117 · Cited by 118
Gabilondo, A., Rojas‐Farreras, S., Vilagut, G., Haro, J. M., Fernández, A., Pinto‐Meza, A., & Alonso, J. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2009.04.016 · Cited by 125
“Higher MDE prevalences are also found when other European countries and studies are considered, especially in Northern and Eastern Europe (Bromet et al., 2005; Kringlen et al., 2001; Pirkola et al., 2005; Wittchen and Jacobi, 2005).”
Adjustment disorder as proposed for ICD-11: Dimensionality and symptom differentiation
Glaesmer, H., Romppel, M., Brähler, E., Hinz, A., & Maercker, A. (2015) · Psychiatry Research · doi:10.1016/j.psychres.2015.07.010 · Cited by 130
Help-seeking and receipt of treatment among UK service personnel
Iversen, A. C., van Staden, L. N., Hughes, J. H., Browne, T., Greenberg, N. L., Hotopf, M. H., Rona, R. J., Wessely, S. C., Thornicroft, G., & Fear, N. T. (2010) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.109.075762 · Cited by 120
Normality and Pathology in a Biomedical Age
Rose, N. (2009) · The Sociological Review · doi:10.1111/j.1467-954x.2010.01886.x · Cited by 113
“Their 2004 study on ‘The Cost of Brain Disorders’ estimated that across 28 European countries (the EU plus Iceland, Norway and Switzerland) with a total population of 466 million, 127 million people or 27 per cent are affected by at least one brain disease and that the total cost of brain disorders amounted to 386 bil…”
BackgroundPerformance monitoring in obsessive–compulsive disorder and social anxiety disorder.
Endraß, T., Riesel, A., Kathmann, N., & Buhlmann, U. (2014) · Journal of Abnormal Psychology · doi:10.1037/abn0000012 · Cited by 123
Comorbidity of Allergic and Autoimmune Diseases Among Patients With ADHD
Chen, M., Su, T., Chen, Y.-S., Hsu, J.-W., Huang, K., Chang, W.-H., Chen, T., & Bai, Y. (2013) · Journal of Attention Disorders · doi:10.1177/1087054712474686 · Cited by 117
“…interest and concern since the 1980s, though with controversial results, because the increase in the prevalence of allergic diseases (i.e., atopic dermatitis [AD], asthma, and allergic rhinitis [AR]) has been matched by a worldwide increase in ADHD diagnoses (Belfer, 2008; Wittchen & Jacobi, 2005).”
ResultBeesdo‐Baum, K., Jacobi, F., Hoyer, J., Low, N. C. P., Höfler, M., & Wïttchen, H. (2009) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-009-0045-1 · Cited by 116
Self-citationKong, X., Boedhoe, P. S. W., Abe, Y., Alonso, P., Ameis, S. H., Arnold, P. D., Assogna, F., Baker, J. T., Batistuzzo, M. C., Benedetti, F., et al. (2019) · Biological Psychiatry · doi:10.1016/j.biopsych.2019.04.022 · Cited by 113
“44. van den Heuvel OA, van Wingen G, Soriano-Mas C, Alonso P, Chamberlain SR, Nakamae T, et al. (2016): Brain circuitry of compulsivity.”
BackgroundInfluentialThe governmentalization of living: calculating global health
Wahlberg, A., & Rose, N. (2015) · Economy and Society · doi:10.1080/03085147.2014.983830 · Cited by 115
“The total annual cost of brain disorders in Europe was estimated to €386 billion in 2004.”
BackgroundInfluentialAdult attachment and social anxiety: The mediating role of emotion regulation strategies
Read, D. L., Clark, G. I., Rock, A. J., & Coventry, W. L. (2018) · PLoS ONE · doi:10.1371/journal.pone.0207514 · Cited by 137
Establishing a trait anxiety threshold that signals likelihood of anxiety disorders
Van Dam, N. T., Gros, D. F., Earleywine, M., & Antony, M. M. (2013) · Anxiety, Stress & Coping · doi:10.1080/10615806.2011.631525 · Cited by 108
Barger, S. D., Messerli‐Bürgy, N., & Barth, J. (2014) · BMC Public Health · doi:10.1186/1471-2458-14-273 · Cited by 118
“Background Depressive disorders affect about one fifth of the population over the life course [1,2] and are associated with impairments in daily functioning and work [3].”
BackgroundA systematic review of adult attachment and social anxiety
Manning, R. P. C., Dickson, J. M., Palmier-Claus, J., Cunliffe, A., & Taylor, P. J. (2017) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.12.020 · Cited by 107
“It is also associated with impairments to quality of life (Wittchen & Jacobi, 2005), romantic relationships (Sparrevohn & Rapee, 2009) and friendships (Davila & Beck, 2002).”
BackgroundEnneking, V., Leehr, E. J., Dannlowski, U., & Redlich, R. (2019) · Psychological Medicine · doi:10.1017/s0033291719003660 · Cited by 113
Hoertel, N., Strat, Y. L., Angst, J., & Dubertret, C. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.09.016 · Cited by 106
“Major depressive disorder (MDD) is considered to be the most prevalent psychiatric disorder, with considerable functional and social impairment (Ustun et al., 2004; Wittchen and Jacobi, 2005).”
BackgroundHegerl, U., Hautzinger, M., Mergl, R., Kohnen, R., Schütze, M., Scheunemann, W., Allgaier, A., Coyne, J., & Henkel, V. (2010) · International Journal of Neuropsychopharmacology · doi:10.1017/s1461145709000224 · Cited by 120
Zou, Y.-F., Ye, D.-Q., Feng, X.-L., Su, H., Pan, F.-M., & Liao, F.-F. (2010) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2009.12.005 · Cited by 104
Prevalence of psychiatric disorders in sick listed chronic low back pain patients
Reme, S. E., Tangen, T., Moe, T., & Eriksen, H. R. (2011) · European Journal of Pain · doi:10.1016/j.ejpain.2011.04.012 · Cited by 104
“Similar rates were found in a review of epidemiological studies from 16 European countries, where a 12 months prevalence of 27% were reported (Wittchen and Jacobi, 2005).”
ResultEffect of 5‐HT1A gene polymorphisms on antidepressant response in major depressive disorder
Kato, M., Fukuda, T., Wakeno, M., Okugawa, G., Takekita, Y., Watanabe, S., Yamashita, M., Hosoi, Y., Azuma, J., Kinoshita, T., et al. (2008) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30783 · Cited by 106
Missinne, S., Vandeviver, C., de Velde, S. V. V., & Bracke, P. (2014) · Social Science Research · doi:10.1016/j.ssresearch.2014.02.006 · Cited by 101
Effectiveness of cognitive behavioural therapy in primary health care: a review.
Høifødt, R., Strøm, C., Kolstrup, N., Eisemann, M., & Waterloo, K. (2011) · Family Practice · doi:10.1093/fampra/cmr017 · Cited by 101
Svensson, B., & Hansson, L. I. (2015) · Nordic Journal of Psychiatry · doi:10.3109/08039488.2015.1109140 · Cited by 104
“This leads to a disability burden corresponding to 25–30% of the total disability-adjusted life years (DALYs) lost in Europe (1).”
BackgroundInfluentialTadić, A., Wagner, S., Höch, J., Başkaya, Ö., von Cube, R., Skaletz, C., Lieb, K., & Dahmen, N. (2009) · Psychopathology · doi:10.1159/000224149 · Cited by 110
Galanin, Galanin Receptor Subtypes and Depression-Like Behaviour
Kuteeva, E., Hökfelt, T. G. M., Wardi, T., & Ögren, S. O. (2010) · Proceedings of the Fourth International Symposium on Polarization Phenomena in Nuclear Reactions · doi:10.1007/978-3-0346-0228-0_12 · Cited by 102
The societal cost of depression: Evidence from 10,000 Swedish patients in psychiatric care
Ekman, M., Granström, O., Omérov, S., Jacob, J., & Landén, M. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2013.03.003 · Cited by 101
“Although there is variability in the epidemiological literature, the 12-month prevalence in a number of relatively large studies varied from 2.1 to 10.1% (Wittchen and Jacobi, 2005).”
BackgroundInfluentialJacobi, F., Mack, S., Gerschler, A., Scholl, L., Höfler, M., Siegert, J., Bürkner, A., Preiss, S., Spitzer, K., Busch, M. A., et al. (2013) · International Journal of Methods in Psychiatric Research · doi:10.1002/mpr.1387 · Cited by 103
Self-citationPrevalence of distress, comorbid conditions and well being in the general population
Wiltink, J., Beutel, M. E., Till, Y., Ojeda, F., Wild, P. S., Münzel, T. F., Blankenberg, S., & Michal, M. (2010) · Journal of Affective Disorders · doi:10.1016/j.jad.2010.10.041 · Cited by 108
“Depressive and panic disorders rank among the disorders with the strongest impact (Wittchen and Jacobi, 2005).”
BackgroundInfluentialNielsen, M. B. D., Madsen, I. E. H., Bültmann, U., Christensen, U., Diderichsen, F., & Rugulies, R. (2010) · European Journal of Public Health · doi:10.1093/eurpub/ckq171 · Cited by 100
Use of Health Care Services by People With Mental Illness
Gäebel, W., Kowitz, S., Fritze, J., & Zielasek, J. (2013) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2013.0799 · Cited by 104
Fineberg, N. A., Hengartner, M. P., Bergbaum, C., Gale, T. M., Wulf Rössler, A., & Angst, J. (2013) · International Journal of Psychiatry in Clinical Practice · doi:10.3109/13651501.2013.777745 · Cited by 104
“Th e lifetime prevalence of these disorders is substantially greater in females than males (Wittchen and Jacobi 2005).”
BackgroundRehm, J. T., Room, R., van den Brinkt, W., & Kraus, L. (2005) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2005.04.004 · Cited by 100
Stapelberg, N. J. C., Hamilton‐Craig, I. R., Neumann, D. L., Shum, D., & McConnell, H. W. (2012) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867412444624 · Cited by 101
“Comorbid anxiety is particularly common in people with depression (Clark et al., 1994) and occurs in about 30–40% of people with MDD between the ages of 18 and 65 years (Wittchen and Jacobi, 2005).”
BackgroundProfessional Fields and Truth Regimes: In Search of Alternative Approaches
Brante, T. (2010) · Comparative Sociology · doi:10.1163/156913310x522615 · Cited by 97
Traumatic Experiences and Posttraumatic Stress Disorder in Soldiers Following Deployment Abroad
Wïttchen, H., Schönfeld, S., Kirschbaum, C., Thurau, C., Trautmann, S., Steudte‐Schmiedgen, S., Klotsche, J., Höfler, M., Hauffa, R., & Zimmermann, P. L. (2012) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2012.0559 · Cited by 99
Panayiotou, G., & Karekla, M. (2013) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-012-0533-6 · Cited by 80
Prevention of anxiety disorders
Bienvenu, O. J., & Ginsburg, G. S. (2007) · International Review of Psychiatry · doi:10.1080/09540260701797837 · Cited by 93
Valenza, G., Gentili, C., Lanatà, A., & Scilingo, E. P. (2013) · Artificial Intelligence in Medicine · doi:10.1016/j.artmed.2012.12.001 · Cited by 96
Effects of expressive writing on depressive symptoms-A meta-analysis
Reinhold, M., Bürkner, P., & Holling, H. (2018) · Clinical Psychology Science and Practice · doi:10.1111/cpsp.12224 · Cited by 110
Brailovskaia, J., Schönfeld, P., Zhang, X. C., Bieda, A., Kochetkov, Y., & Margraf, J. (2017) · Psychological Reports · doi:10.1177/0033294117727745 · Cited by 112
“Therefore, depression and anxiety disorders belong to the most prevalent diagnoses (Trumpf et al., 2010; Wittchen & Jacobi, 2005).”
BackgroundMcDaid, D., Knapp, M. R. J., & Raja, S. (2008) · World Psychiatry · doi:10.1002/j.2051-5545.2008.tb00160.x · Cited by 93
Dell’Osso, B. M., Buoli, M., Baldwin, D. S., & Altamura, A. C. (2009) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.1074 · Cited by 94
Metadata
- Authors
- Wittchen, H.-U., & Jacobi, F.
- Affiliations
- Max Planck Institute of Psychiatry (DE)
- ORCID
- Jacobi, Frank
- Venue
- European Neuropsychopharmacology
- Publisher
- Elsevier BV
- Published
- 2005-08
- Volume
- 15
- Issue
- 4
- Pages
- 357-376
- ISSN
- 0924-977X (ISSN-L)
- OpenAlex
- W2107900025
- Cited by
- 1,503
- References
- 140
- Citations by year
- 2026: 14 · 2025: 31 · 2024: 43 · 2023: 64 · 2022: 48 · 2021: 46 · 2020: 57 · 2019: 58 · 2018: 64 · 2017: 75 · 2016: 83 · 2015: 84 · 2014: 103 · 2013: 110 · 2012: 121
- FWCI
- 96.18
- Type
- journal article
- Language
- en
- Open access
- green
- tud.qucosa.de
- Licence
- Locations
- European Neuropsychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Max Planck Institute for Plasma Physics (submittedVersion)
- Qucosa (Saxon State and University Library Dresden) (submittedVersion, other-oa)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Health and Medical Studies
- Social Sciences › Psychology › Clinical Psychology › Psychiatric care and mental health services
- Keywords
- mental illness, prevalence, disability burden, treatment utilization, unmet needs, comorbidities, anxiety disorders, depression, somatoform disorders, substance dependence, lost workdays, European Union, cross-national comparison, adolescent mental health, older adults
- MeSH terms
- Absenteeism, Adolescent, Adult, Age Factors, Aged, Mental Disorders, Disability Evaluation, Europe, Female, Humans, Male, Mental Health Services, Middle Aged, Quality of Life, Residence Characteristics, Review Literature as Topic, Sex Factors, Comorbidity, Prevalence, Cost of Illness, Diagnosis, Dual (Psychiatry), Quality-Adjusted Life Years
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review